vs

Side-by-side financial comparison of KORU Medical Systems, Inc. (KRMD) and US Foods Holding Corp. (USFD). Click either name above to swap in a different company.

KORU Medical Systems, Inc. is the larger business by last-quarter revenue ($11.8B vs $9.6B, roughly 1.2× US Foods Holding Corp.). On growth, KORU Medical Systems, Inc. posted the faster year-over-year revenue change (22.1% vs 2.8%). Over the past eight quarters, KORU Medical Systems, Inc.'s revenue compounded faster (3635.7% CAGR vs -0.5%).

KORU Medical Systems, Inc. is a specialized medical technology company that designs, manufactures, and distributes innovative ambulatory infusion systems and supporting disposable products. It caters to healthcare providers and patients across home care, clinical trial, and acute care segments worldwide, with a focus on enhancing the safety and comfort of specialty medication delivery.

US Foods Holding Corp. is an American food service distributor. It is the second-largest food service distributor in the U.S., after Sysco. The company supplies 250,000 locations including independent restaurants, chain restaurants, healthcare, hospitality, and educational institutions.

KRMD vs USFD — Head-to-Head

Bigger by revenue
KRMD
KRMD
1.2× larger
KRMD
$11.8B
$9.6B
USFD
Growing faster (revenue YoY)
KRMD
KRMD
+19.3% gap
KRMD
22.1%
2.8%
USFD
Faster 2-yr revenue CAGR
KRMD
KRMD
Annualised
KRMD
3635.7%
-0.5%
USFD

Income Statement — Q1 FY2026 vs Q1 FY2027

Metric
KRMD
KRMD
USFD
USFD
Revenue
$11.8B
$9.6B
Net Profit
$116.0M
Gross Margin
61.5%
17.2%
Operating Margin
31.2%
2.2%
Net Margin
1.2%
Revenue YoY
22.1%
2.8%
Net Profit YoY
0.9%
EPS (diluted)
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRMD
KRMD
USFD
USFD
Q1 26
$11.8B
$9.6B
Q4 25
$10.9M
$9.8B
Q3 25
$10.4M
$10.2B
Q2 25
$10.2M
$10.1B
Q1 25
$9.6M
$9.4B
Q4 24
$8.8M
$9.5B
Q3 24
$8.2M
$9.7B
Q2 24
$8.4M
$9.7B
Net Profit
KRMD
KRMD
USFD
USFD
Q1 26
$116.0M
Q4 25
$184.0M
Q3 25
$-778.0K
$153.0M
Q2 25
$-206.9K
$224.0M
Q1 25
$-1.2M
$115.0M
Q4 24
$66.0M
Q3 24
$-1.6M
$148.0M
Q2 24
$-988.7K
$198.0M
Gross Margin
KRMD
KRMD
USFD
USFD
Q1 26
61.5%
17.2%
Q4 25
62.6%
17.6%
Q3 25
60.2%
17.2%
Q2 25
63.5%
17.6%
Q1 25
62.8%
17.3%
Q4 24
62.9%
17.6%
Q3 24
63.4%
17.1%
Q2 24
65.0%
17.6%
Operating Margin
KRMD
KRMD
USFD
USFD
Q1 26
31.2%
2.2%
Q4 25
-5.0%
3.3%
Q3 25
-8.3%
2.8%
Q2 25
-3.1%
3.7%
Q1 25
-12.9%
2.4%
Q4 24
-18.0%
3.2%
Q3 24
-20.8%
2.9%
Q2 24
-14.1%
3.6%
Net Margin
KRMD
KRMD
USFD
USFD
Q1 26
1.2%
Q4 25
1.9%
Q3 25
-7.5%
1.5%
Q2 25
-2.0%
2.2%
Q1 25
-12.1%
1.2%
Q4 24
0.7%
Q3 24
-19.3%
1.5%
Q2 24
-11.7%
2.0%
EPS (diluted)
KRMD
KRMD
USFD
USFD
Q1 26
$0.52
Q4 25
$-0.11
$0.82
Q3 25
$0.02
$0.67
Q2 25
$0.00
$0.96
Q1 25
$0.03
$0.49
Q4 24
$-0.22
$0.28
Q3 24
$0.03
$0.61
Q2 24
$0.02
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRMD
KRMD
USFD
USFD
Cash + ST InvestmentsLiquidity on hand
$8.8B
$49.0M
Total DebtLower is stronger
$5.2B
Stockholders' EquityBook value
$4.3B
Total Assets
$28.6B
$14.2B
Debt / EquityLower = less leverage
1.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRMD
KRMD
USFD
USFD
Q1 26
$8.8B
$49.0M
Q4 25
$8.9M
$41.0M
Q3 25
$8.5M
$56.0M
Q2 25
$8.1M
$61.0M
Q1 25
$8.7M
$101.0M
Q4 24
$9.6M
$59.0M
Q3 24
$8.8M
$81.0M
Q2 24
$10.5M
$405.0M
Total Debt
KRMD
KRMD
USFD
USFD
Q1 26
$5.2B
Q4 25
$5.1B
Q3 25
$4.8B
Q2 25
$4.7B
Q1 25
$4.7B
Q4 24
$4.8B
Q3 24
$4.7B
Q2 24
$4.6B
Stockholders' Equity
KRMD
KRMD
USFD
USFD
Q1 26
$4.3B
Q4 25
$17.0M
$4.3B
Q3 25
$16.5M
$4.5B
Q2 25
$16.5M
$4.6B
Q1 25
$16.3M
$4.6B
Q4 24
$16.8M
$4.5B
Q3 24
$17.7M
$4.6B
Q2 24
$18.7M
$5.0B
Total Assets
KRMD
KRMD
USFD
USFD
Q1 26
$28.6B
$14.2B
Q4 25
$28.2M
$13.9B
Q3 25
$27.1M
$14.0B
Q2 25
$25.5M
$13.8B
Q1 25
$27.2M
$13.7B
Q4 24
$27.2M
$13.4B
Q3 24
$27.4M
$13.5B
Q2 24
$27.3M
$13.7B
Debt / Equity
KRMD
KRMD
USFD
USFD
Q1 26
1.19×
Q4 25
1.18×
Q3 25
1.08×
Q2 25
1.02×
Q1 25
1.02×
Q4 24
1.06×
Q3 24
1.01×
Q2 24
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRMD
KRMD
USFD
USFD
Operating Cash FlowLast quarter
$294.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.53×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRMD
KRMD
USFD
USFD
Q1 26
$294.0M
Q4 25
$1.1M
$293.0M
Q3 25
$65.5K
$351.0M
Q2 25
$-460.3K
$334.0M
Q1 25
$-237.5K
$391.0M
Q4 24
$939.6K
$283.0M
Q3 24
$-923.9K
$270.0M
Q2 24
$11.3K
$482.0M
Free Cash Flow
KRMD
KRMD
USFD
USFD
Q1 26
Q4 25
$687.0K
$159.0M
Q3 25
$13.0K
$236.0M
Q2 25
$-489.2K
$257.0M
Q1 25
$-680.9K
$307.0M
Q4 24
$896.0K
$178.0M
Q3 24
$-2.0M
$190.0M
Q2 24
$-112.9K
$413.0M
FCF Margin
KRMD
KRMD
USFD
USFD
Q1 26
Q4 25
6.3%
1.6%
Q3 25
0.1%
2.3%
Q2 25
-4.8%
2.5%
Q1 25
-7.1%
3.3%
Q4 24
10.1%
1.9%
Q3 24
-24.5%
2.0%
Q2 24
-1.3%
4.3%
Capex Intensity
KRMD
KRMD
USFD
USFD
Q1 26
Q4 25
3.7%
1.4%
Q3 25
0.5%
1.1%
Q2 25
0.3%
0.8%
Q1 25
4.6%
0.9%
Q4 24
0.5%
1.1%
Q3 24
13.2%
0.8%
Q2 24
1.5%
0.7%
Cash Conversion
KRMD
KRMD
USFD
USFD
Q1 26
2.53×
Q4 25
1.59×
Q3 25
2.29×
Q2 25
1.49×
Q1 25
3.40×
Q4 24
4.29×
Q3 24
1.82×
Q2 24
2.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons